SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

SMTL ID : 6i3u.1

Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study in Huntington's disease models

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.09 Å
Oligo State
monomer
Ligands
1 x H2E: 2-morpholin-4-yl-6-[7-[(2~{R})-1-morpholin-4-ylpropan-2-yl]oxy-9~{H}-thioxanthen-4-yl]pyran-4-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Toledo-Sherman, L. et al., Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models. J.Med.Chem. (2019)
Release Date
2019-03-20
Peptides
Phosphatidylinositol 3-kinase catalytic subunit type 3: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Phosphatidylinositol 3-kinase catalytic subunit type 3